Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding / 2026-03-30 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-04-10 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – DS Investment & Securities | HBM & QLC eSSD Growth · 2025 Earnings Upgrade · Target Price Raised / 2024-06-24 RESEARCH
  • [Disclosure] SK Square (402340) – Results of Annual General Meeting of Shareholders / 2026-03-25 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-11-18 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Submission of Audit Report / 2026-03-04 Disclosures
  • [Disclosure] Hanmi Semiconductor(042700) – Decision on Acquisition of Tangible Assets / 2024-05-14 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Share Cancellation Decision / 2024-03-21 Automotive

[Disclosure] Celltrion (068270) – Provisional Sales Performance / 2025-05-09

Posted on May 9, 2025August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion announced its provisional Q1 2025 separate financial results, reporting revenue of approximately KRW 634.0B and operating profit of KRW 136.4B. While revenue and operating profit decreased compared to the previous quarter, operating profit grew by over 370% year-over-year.

📊 Key Disclosure Content & Financial Highlights

  1. Overview
  • Company: Celltrion, Inc. (Stock Code: 068270)
  • Disclosure Type: Provisional Sales Performance (Fair Disclosure)
  • Financial Basis: Separate Financial Statements (Internal Unaudited Results)
  • Period: Q1 2025
  1. Key Financial Performance for Q1 2025
  • Revenue:
    • Current Quarter: KRW 634.007B (634,007 million KRW)
    • QoQ (vs. Q4 2024): -40.07%
    • YoY (vs. Q1 2024): -0.66%
  • Operating Profit:
    • Current Quarter: KRW 136.423B (136,423 million KRW)
    • QoQ (vs. Q4 2024): -66.52%
    • YoY (vs. Q1 2024): +373.94%
  • Profit Before Income Tax Expenses from Continuing Operations:
    • Current Quarter: KRW 203.022B (203,022 million KRW)
    • QoQ (vs. Q4 2024): -58.19%
    • YoY (vs. Q1 2024): +311.58%
  • Net Income:
    • Current Quarter: KRW 166.572B (166,572 million KRW)
    • QoQ (vs. Q4 2024): -56.00%
    • YoY (vs. Q1 2024): +173.37%
  1. Additional Notes
  • The above figures are provisional internal accounting figures and are subject to change depending on the external audit results.
  • Further details can be found in the IR presentation materials (Korean/English) on Celltrion’s official website.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Comparison Between Unaudited Provisional Figures and Final Audited Figures

This disclosure presents provisional figures based on internal accounting prior to the completion of the external audit. Verifying any variances between these preliminary estimates and the final audited figures is essential for understanding how the performance is accurately reflected in the actual profit and financial condition. Relevant details can be confirmed through upcoming periodic reports or official IR materials on the company website.

📢 Disclaimer & Source Notice

Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Consolidated Provisional Financial Results / 2025-05-09
Next Post: [Disclosure] KEPCO (015760 / KEP) – Decision to Convene General Meeting of Shareholders / 2025-05-09

Related Posts

  • [Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-06-10 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Other Information / 2024-06-19 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Change in Revenue or P&L Structure Exceeding 30% (15% for Large Corporations) / 2025-01-23 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Debt Guarantee for Others / 2025-12-24 Disclosures
  • [Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-12-20 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Sustainability Report and Related Matters (Voluntary Disclosure) / 2025-09-05 Disclosures
  • [Disclosure] SK Square (402340) – Occurrence of Serious Industrial Accident / 2026-06-26 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2026-01-29 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Filing of Legal Proceedings / 2026-05-22 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-02-18 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Investor Relations (IR) Holding Announcement / 2026-05-08 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Termination of Trust Contract for Treasury Stock Acquisition / 2025-03-24 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Other Major Management Matters (Voluntary Disclosure) / 2024-10-31 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme